Cytogen, Inc. (KOSDAQ: 217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,480.00
+80.00 (1.48%)
Dec 20, 2024, 9:00 AM KST

Cytogen Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
126,421257,276289,471355,717
Market Cap Growth
-46.46%-11.12%-18.62%-
Enterprise Value
96,839266,578284,261-
Last Close Price
5480.0013520.0016200.0020400.00
PS Ratio
19.1280.79380.491022.63
PB Ratio
2.174.8251.1815.46
P/TBV Ratio
4.105.62-16.53
EV/Sales Ratio
15.6683.71373.65-
Debt / Equity Ratio
0.250.334.671.07
Asset Turnover
0.110.060.02-
Inventory Turnover
7.2529.83--
Quick Ratio
10.765.180.555.31
Current Ratio
11.415.210.576.42
Return on Equity (ROE)
-46.56%-53.45%-130.97%-
Return on Assets (ROA)
-13.50%-12.74%-14.85%-
Return on Capital (ROIC)
-15.82%-14.31%-18.03%-
Earnings Yield
-13.53%-6.13%-6.48%-3.06%
FCF Yield
-8.24%-3.92%-2.43%-1.81%
Buyback Yield / Dilution
-20.02%-3.54%-4.24%-
Total Shareholder Return
-20.02%-3.54%-4.24%-
Source: S&P Capital IQ. Standard template. Financial Sources.